Search tips
Search criteria 


Logo of gutGutView this articleSubmit a manuscriptReceive email alertsContact usBMJ
Gut. 1982 December; 23(12): 1088–1093.
PMCID: PMC1419855

Treatment of alcohol-related liver disease with thioctic acid: a six month randomised double-blind trial.


A randomised double-blind trial of thioctic acid (alpha-lipoic acid), 300 mg/day versus placebo was carried out in 40 patients with pre-cirrhotic alcohol-related liver disease over a six month period. Twenty patients received the active drug and 20 placebo. Twenty-two of the 40 patients (55%) abstained from alcohol and showed significant improvements (p less than 0.01) in mean values for serum aspartate transaminase, serum glutamyl transpeptidase, and mean corpuscular volume. Seventeen of the 22 (77%) showed overall histological improvement on liver biopsy. The remaining 18 patients (45%) continued to drink but significantly reduced their mean daily alcohol intake (p less than 0.001). No significant changes occurred in their laboratory indices, but five of the 18 (28%) showed overall histological improvement. Changes occurred irrespective of treatment with thioctic acid, which suggested that, over six months, this drug did not influence the course of alcohol-related liver disease.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (614K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Kershenobich D, Uribe M, Suárez GI, Mata JM, Pérez-Tamayo R, Rojkind M. Treatment of cirrhosis with colchicine. A double-blind randomized trial. Gastroenterology. 1979 Sep;77(3):532–536. [PubMed]
  • Colman JC, Morgan MY, Scheuer PJ, Sherlock S. Treatment of alcohol-related liver disease with (+)-cyanidanol-3: a randomised double-blind trial. Gut. 1980 Nov;21(11):965–969. [PMC free article] [PubMed]
  • REED LJ. Metabolic functions of thiamine and lipoic acid. Physiol Rev. 1953 Oct;33(4):544–559. [PubMed]
  • Marnett LJ, Wilcox CL. Stimulation of prostaglandin biosynthesis by lipoic acid. Biochim Biophys Acta. 1977 Apr 26;487(1):222–230. [PubMed]
  • Egan RW, Gale PH, Beveridge GC, Phillips GB, Marnett LJ. Radical scavenging as the mechanism for stimulation of prostaglandin cyclooxygenase and depression of inflammation by lipoic acid and sodium iodide. Prostaglandins. 1978 Dec;16(6):861–869. [PubMed]
  • Möller E, Brinkmann W, Weber O, Wildhirt E. Behandlung chronischer Leberkrankheiten mit Thioktsäure. Med Klin. 1967 Mar 10;62(10):380–384. [PubMed]
  • DITTRICH H, SEIFERT E. [Clinical applicability of thioctic acid]. Munch Med Wochenschr. 1962 Oct 26;104:2053–2056. [PubMed]
  • Frimmer M, Waldvogel G, Weil G. Schutzwirkung von Thioctsäure gegen die Kalium-freisetzende Wirkung des Phalloidins an der isoliert perfundierten Rattenleber. Klin Wochenschr. 1968 Dec 1;46(23):1288–1289. [PubMed]
  • Lieber CS. Liver adaptation and injury in alcoholism. N Engl J Med. 1973 Feb 15;288(7):356–362. [PubMed]

Articles from Gut are provided here courtesy of BMJ Publishing Group